Press

If you are a member of the media and need help with a story or want to arrange an interview with an AABB spokesperson, please contact AABB’s Public Relations Department by emailing publicrelations@aabb.org or dialing +1.301.215.6526.

2023 Press Releases

AABB Provides Complimentary Resources for Blood Community to Aid in Implementation of Individual Donor Assessments

07/17/2023

AABB is pleased to offer a resource library with training materials and job aids for U.S. blood collection facilities as they prepare for the implementation of IDA protocols.
Jeff Wren to Join AABB as Vice President, Biotherapies

07/12/2023

AABB announced today that Jeff Wren, MBA, will join the Association as vice president, biotherapies. He will begin his new role on July 17.
AABB Applauds FDA’s Final Guidance Recommending Individual Donor Assessment for Blood Donor Eligibility

05/11/2023

AABB applauds the Food and Drug Administration for issuing a final guidance that recommends determining blood donor eligibility based on an individual assessment.
AABB Applauds FDA’s Recommendations to Implement Individual Risk Assessment for Blood Donors

01/31/2023

AABB applauds the FDA for its recent draft guidance recommending blood donor eligibility be based on an individual’s behavior and risks, regardless of the donor’s gender or sexual orientation.
AABB Introduces New Biotherapies Corporate Membership Program

01/12/2023

AABB is proud to introduce the AABB Biotherapies Corporate Membership Program, an initiative designed to ease challenges that biotherapies companies face, including workforce development, quality systems control and regulatory support.
Blood Community Unites to Thank America’s Donors this National Blood Donor Month

01/04/2023

AABB, America’s Blood Centers (ABC) and the American Red Cross are joining together to thank America’s more than 7 million blood donors as they mark National Blood Donor Month.

2022 Press Releases

AABB Congratulates Inaugural CABP Cohort

12/19/2022

Biotherapies professionals achieving this distinction have demonstrated their qualifications by meeting pre-requisites and passing an exam that covered seven domains of the field.
As Hurricane Ian Makes Landfall, Individuals in Unaffected Areas Urged to Donate Blood

09/28/2022

As Hurricane Ian reaches Florida, the AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism strongly urges eligible individuals in unaffected areas throughout the U.S. to schedule a donation appointment as soon as possible.
Fresenius Kabi and AABB Celebrate 17th Annual Blood Collectors Week from Sept. 4-10

09/04/2022

Honoring blood collection professionals and their lifesaving impact on patient care
AABB Introduces New Biotherapies Credentialing Program

08/19/2022

The Association for the Advancement of Blood & Biotherapies (AABB) recently introduced the AABB Certified Advanced Biotherapies Professional (CABP) credentialing program. This is the first and only certification for biotherapies professionals.
AABB Appoints Sharon Carayiannis as Vice President, Science and Practice

03/18/2022

AABB is pleased to announce the appointment of Sharon Carayiannis, BSMT(ASCP)HP, as its vice president for Science and Practice. Carayiannis has served AABB in this role on an interim basis since October 2021.
AABB Launches New Alliance to Support the U.S. Blood Supply

02/04/2022

The Alliance for a Strong Blood Supply aims to improve the resilience of the blood supply.

2021 Press Releases

AABB Statement in Support of the Improving Access to Transfusion Care for Hospice Patients Act of 2021

07/30/2021

AABB applauds Senators Rosen, Barrasso and Baldwin for their bipartisan legislation to expand access to blood transfusion through the Improving Access to Transfusion Care for Hospice Patients Act of 2021.

Press

2023 Press Releases

2022 Press Releases

2021 Press Releases

2020 Press Releases

2019 Press Releases

2018 Press Releases